Cargando…
CRISPR-Cas Genome Surgery in Ophthalmology
Genetic disease affecting vision can significantly impact patient quality of life. Gene therapy seeks to slow the progression of these diseases by treating the underlying etiology at the level of the genome. Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated sys...
Autores principales: | DiCarlo, James E., Sengillo, Jesse D., Justus, Sally, Cabral, Thiago, Tsang, Stephen H., Mahajan, Vinit B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450921/ https://www.ncbi.nlm.nih.gov/pubmed/28573077 http://dx.doi.org/10.1167/tvst.6.3.13 |
Ejemplares similares
-
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases
por: Xu, Christine L., et al.
Publicado: (2018) -
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
por: Sengillo, Jesse D., et al.
Publicado: (2017) -
Retrospective Analysis of Structural Disease Progression in Retinitis Pigmentosa Utilizing Multimodal Imaging
por: Cabral, Thiago, et al.
Publicado: (2017) -
Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients
por: Sengillo, Jesse D., et al.
Publicado: (2017) -
Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
por: Boudreault, Katherine, et al.
Publicado: (2017)